)
Visual
earnings real time
Coloplast (COLO) investor relations material
Coloplast Q4 24/25 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 24/25 earnings summary4 Nov, 2025
Executive summary
Achieved 7% organic growth and 3% reported revenue growth to DKK 27,874 million for FY 2024/25, with an EBIT margin before special items of 28%, in line with revised guidance and supported by broad-based growth in core business areas, but below initial expectations.
Chronic care (excluding China) and Kerecis performed well, while interventional urology and advanced wound dressings faced challenges due to product recalls, market volatility, and a product return in China.
Business restructured in China to address muted performance and competitive pressures; profitability initiatives included the divestment of the skincare business in December 2024.
New strategy, Impact Four, launched with focus on innovation, efficiency, technology (including AI), and sustainability, targeting 7-8% organic growth CAGR and ROIC >20% by 2029/30.
Free cash flow (adjusted) rose 32% to DKK 5,202 million, with a FCF-to-sales ratio of 19%.
Financial highlights
Revenue: DKK 27,874 million (+3% year-over-year); organic growth 7%, with -1.3% from divestments and -2.2% from currency effects.
EBIT before special items: DKK 7,670 million (+5%); EBIT margin before special items: 28% (up from 27%).
Adjusted net profit before special items: DKK 5,148 million (+2%); adjusted diluted EPS: DKK 22.84 (+2%).
Free cash flow: DKK 5,394 million, with adjusted free cash flow-to-sales ratio at 19% (up from 15%).
Gross margin stable at 68%; operating expenses up 3% to DKK 11,275 million.
Outlook and guidance
FY 2025/26 guidance: ~7% organic revenue growth, ~7% EBIT growth in constant currencies, ROIC around 16%.
Reported revenue growth in DKK expected at 4-5%, with 2-3 percentage points negative currency impact and minor effect from skin care divestment.
Net profit expected to increase significantly year-over-year due to normalization of special items and tax expenses.
Capex-to-sales ratio expected at 5%; effective tax rate around 22%.
Impact4 strategy targets 7-8% organic growth CAGR and ROIC >20% by 2029/30.
Kerecis: Impact of new CMS payment rule?
Impact4 investments: Key focus areas?
China market: Strategy to address challenges?
Kerecis: How will new LCD policy affect market?
Impact4: Key investment areas and expected returns?
China Ostomy: How to address flat growth, competition?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Coloplast earnings date
Q1 25/266 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Coloplast A/S engages in the development and sale of intimate healthcare products and services. The company offers urology products, such as bladder catheters, external urinary catheter systems, balloon dilators for benign prostatic hyperplasia treatment, stents and grafts, urological drainage bags, and colostomy bags; orthopedic products consisting of sheets with fixation areas, meshes with fixation areas and meshes marketed together with other devices.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage